Clinical Trial Update: ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill ICG- Livertest Versus New Biomarkers as Prognostic Markers in Critically Ill

View source ↗

Summary

An update on a clinical trial comparing the ICG-Livertest biomarker test against new biomarkers for prognosis in critically ill patients. The sponsor is the Uni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness

Snippet

Sponsor: University of Zurich | Conditions: Critically Ill Patients | Status: UNKNOWN